Landfar Bio-medicine Balance Sheet Health
Financial Health criteria checks 6/6
Landfar Bio-medicine has a total shareholder equity of CN¥301.2M and total debt of CN¥13.3M, which brings its debt-to-equity ratio to 4.4%. Its total assets and total liabilities are CN¥594.1M and CN¥292.9M respectively.
Key information
4.4%
Debt to equity ratio
CN¥13.28m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥315.27m |
| Equity | CN¥301.20m |
| Total liabilities | CN¥292.88m |
| Total assets | CN¥594.09m |
Recent financial health updates
No updates
Recent updates
There's Reason For Concern Over Landfar Bio-medicine Co., Ltd's (SZSE:000504) Massive 37% Price Jump
Oct 21
Risks Still Elevated At These Prices As Landfar Bio-medicine Co., Ltd (SZSE:000504) Shares Dive 31%
Jun 09Landfar Bio-medicine Co., Ltd's (SZSE:000504) Popularity With Investors Under Threat As Stock Sinks 32%
Apr 17Landfar Bio-medicine Co., Ltd (SZSE:000504) Investors Are Less Pessimistic Than Expected
Mar 01Financial Position Analysis
Short Term Liabilities: 000504's short term assets (CN¥492.9M) exceed its short term liabilities (CN¥269.1M).
Long Term Liabilities: 000504's short term assets (CN¥492.9M) exceed its long term liabilities (CN¥23.8M).
Debt to Equity History and Analysis
Debt Level: 000504 has more cash than its total debt.
Reducing Debt: 000504's debt to equity ratio has reduced from 173.1% to 4.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 000504 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 000504 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 27.2% per year.